Published in Hepatitis Weekly, January 30th, 2006
"In this study," wrote C. Jorns and colleagues, Institute of Medical Microbiology and Hygiene, "a novel assay system based on the IFN-inducible Mx-promoter was used to detect IFN-neutralizing antibodies in sera of patients with chronic hepatitis C."
"To monitor IFN bioactivity in IFN-treated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly